Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
LogicBio Therapeutics
Biotech
AstraZeneca pays 666% premium to buy genomic medicine biotech
Working through its Alexion rare disease unit, the Big Pharma has struck a deal to snap up struggling LogicBio to secure technology and expertise.
Nick Paul Taylor
Oct 3, 2022 9:00am
LogicBio's sun and shares rise after FDA releases clinical hold
May 9, 2022 11:00am
FDA puts LogicBio genome editing therapy trial on hold
Feb 2, 2022 8:10am
Intellia, LogicBio fuel hope for in vivo gene editing: report
Oct 25, 2021 10:37am
Next-gen gene therapies for rare diseases forge ahead
Dec 14, 2020 5:28am
LogicBio rocked by FDA clinical hold on genome editing trial
Feb 11, 2020 8:30am
